Literature DB >> 8406611

Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2.

T R Bauer1, H E McDermid, M L Budarf, M L Van Keuren, B B Blomberg.   

Abstract

The human immunoglobulin lambda-like (IGLL) genes, which are homologous to the human immunoglobulin lambda (IGL) light chain genes, are expressed only in pre-B cells and are involved in B cell development. Three IGLL genes, 14.1, 16.1, and 16.2 are present in humans as opposed to one, lambda 5 (Igll), found in the mouse. To precisely map the location of the human IGLL genes in relation to each other and to the human IGL gene locus, at 22q11.1-2, a somatic cell hybrid panel and pulsed field gel electrophoresis (PFGE) were used. Hybridization with a lambda-like gene-specific DNA probe to somatic cell hybrids revealed that these genes reside on 22q11.2 between the breakpoint cluster region (BCR) and the Ewing sarcoma breakpoint at 22q12 and that gene 16.1 was located distal to genes 14.1 and 16.2. Gene 14.1 was found by PFGE to be proximal to 16.2 by at least 30 kilobases (kb). A 210 kb Not I fragment containing genes 14.1 and 16.2 is adjacent to a 400 kb Not I fragment containing the BCR locus, which is just distal to the IGL-C (IGL constant region) genes. We have determined that the IGLL genes 14.1 and 16.2 are approximately 670 kb and 690 to 830 kb distal, respectively, to the 3'-most IGL-C gene in the IGL gene locus, IGL-C7. We thus show the first physical linkage of the IGL and the IGLL genes, 14.1 and 16.2. We discuss the relevance of methylation patterns and CpG islands to expression, and the evolutionary significance of the IGLL gene duplications. Consistent with the GenBank nomenclature, these human IGLL genes will be referred to as IGLL1 (14.1), IGLL2 (16.2), and IGLL3 (16.1), reflecting their position on chromosome 22, as established by this report.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406611     DOI: 10.1007/bf00184519

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  55 in total

1.  The IGLJ6 joining segment as a STS in the human immunoglobulin lambda light chain constant region gene locus (located at 22q11).

Authors:  M A Poul; X M Zhang; F Ducret; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

2.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

3.  Molecular cloning of a human immunoglobulin lambda chain variable sequence.

Authors:  Y Tsujimoto; C M Croce
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

4.  Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.

Authors:  J Knight; P Laing; A Knight; D Adams; N Ling
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

5.  A deletion in chromosome 22 can cause DiGeorge syndrome.

Authors:  A de la Chapelle; R Herva; M Koivisto; P Aula
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  The human lambda L chain Ig locus. Recharacterization of JC lambda 6 and identification of a functional JC lambda 7.

Authors:  T R Bauer; B Blomberg
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Organization and expression of the lambda-like genes that contribute to the mu-psi light chain complex in human pre-B cells.

Authors:  D Bossy; M Milili; J Zucman; G Thomas; M Fougereau; C Schiff
Journal:  Int Immunol       Date:  1991-11       Impact factor: 4.823

8.  Organization of four mouse lambda light chain immunoglobulin genes.

Authors:  B Blomberg; A Traunecker; H Eisen; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  Comparative mapping of the constitutional and tumor-associated 11;22 translocations.

Authors:  M Budarf; B Sellinger; C Griffin; B S Emanuel
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

10.  Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes.

Authors:  O W McBride; P A Hieter; G F Hollis; D Swan; M C Otey; P Leder
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  5 in total

1.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

2.  Composite exon structure of an unusual Ig lambda-like gene located at human 22q11 position.

Authors:  C Schiff; M Milili; J Zucman-Rossi; M Djabali; M Fougereau
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

3.  Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.

Authors:  Y Minegishi; E Coustan-Smith; Y H Wang; M D Cooper; D Campana; M E Conley
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

4.  Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.

Authors:  Arianna Aricò; Serena Ferraresso; Silvia Bresolin; Laura Marconato; Stefano Comazzi; Geertruy Te Kronnie; Luca Aresu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

5.  Risk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function.

Authors:  Yulan Jin; Ashok Sharma; Shan Bai; Colleen Davis; Haitao Liu; Diane Hopkins; Kathy Barriga; Marian Rewers; Jin-Xiong She
Journal:  Diabetes       Date:  2014-03-04       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.